-
1
-
-
0008461995
-
Chronic neutropenia mediated by Fas ligand
-
Liu JH, Wei S, Lamy T, et al. Chronic neutropenia mediated by Fas ligand. Blood 2000; 95: 3219-22.
-
(2000)
Blood
, vol.95
, pp. 3219-3222
-
-
Liu, J.H.1
Wei, S.2
Lamy, T.3
-
2
-
-
0028807486
-
Interleukin-12 is a costimulatory cytokine for leukemic CD3+ large granular lymphocytes
-
Gentile TC, Loughran TP, Jr. Interleukin-12 is a costimulatory cytokine for leukemic CD3+ large granular lymphocytes. Cell Immunol 1995; 166: 158-61.
-
(1995)
Cell Immunol
, vol.166
, pp. 158-161
-
-
Gentile, T.C.1
Loughran Jr., T.P.2
-
3
-
-
0030034649
-
IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes
-
Zambello R, Trentin L, Cassatella MA, et al. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Br J Haematol 1996; 92: 308-14.
-
(1996)
Br J Haematol
, vol.92
, pp. 308-314
-
-
Zambello, R.1
Trentin, L.2
Cassatella, M.A.3
-
4
-
-
0031038352
-
Interleukin- 15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes
-
Zambello R, Facco M, Trentin L, et al. Interleukin- 15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 1997; 89: 201-11.
-
(1997)
Blood
, vol.89
, pp. 201-211
-
-
Zambello, R.1
Facco, M.2
Trentin, L.3
-
6
-
-
36048998093
-
High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS
-
Cario G, Izraeli S, Teichert A, et al. High interleukin-15 expression characterizes childhood acute lymphoblastic leukemia with involvement of the CNS. J Clin Oncol 2007; 25: 4813-20.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4813-4820
-
-
Cario, G.1
Izraeli, S.2
Teichert, A.3
-
7
-
-
0037003871
-
IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis
-
Losy J, Niezgoda A, Zaremba J. IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis. Folia Neuropathol 2002; 40: 151-3.
-
(2002)
Folia Neuropathol
, vol.40
, pp. 151-153
-
-
Losy, J.1
Niezgoda, A.2
Zaremba, J.3
-
8
-
-
0031042456
-
Interleukin- 15 mediates T cell-dependent regulation of tumor necrosis factor-αproduction in rheumatoid arthritis
-
McInnes IB, Leung BP, Sturrock RD, et al. Interleukin- 15 mediates T cell-dependent regulation of tumor necrosis factor-αproduction in rheumatoid arthritis. Nat Med 1997; 3: 189-95.
-
(1997)
Nat Med
, vol.3
, pp. 189-195
-
-
McInnes, I.B.1
Leung, B.P.2
Sturrock, R.D.3
-
9
-
-
4444240035
-
Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokineactivated killer cells in celiac disease
-
Meresse B, Chen Z, Ciszewski C, et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokineactivated killer cells in celiac disease. Immunity 2004; 21: 357-66.
-
(2004)
Immunity
, vol.21
, pp. 357-366
-
-
Meresse, B.1
Chen, Z.2
Ciszewski, C.3
-
10
-
-
0028179054
-
Cloning of a T cell growth factor that interacts with the h chain of the interleukin-2 receptor
-
Grabstein KH, Eisenman J, ShanebeckK, et al. Cloning of a T cell growth factor that interacts with the h chain of the interleukin-2 receptor. Science 1994; 264: 965-8.
-
(1994)
Science
, vol.264
, pp. 965-968
-
-
Grabstein, K.H.1
Eisenman, J.2
ShanebeckK3
-
11
-
-
0028131273
-
Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
-
Carson WE, Giri JG, Lindemann MJ, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180: 1395-403.
-
(1994)
J Exp Med
, vol.180
, pp. 1395-1403
-
-
Carson, W.E.1
Giri, J.G.2
Lindemann, M.J.3
-
12
-
-
0030906448
-
A potential role for interleukin-15 in the regulation of human natural killer cell survival
-
Carson WE, Fehniger TA, Haldar S, et al. A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 1997; 99: 937-43.
-
(1997)
J Clin Invest
, vol.99
, pp. 937-943
-
-
Carson, W.E.1
Fehniger, T.A.2
Haldar, S.3
-
13
-
-
0034610970
-
Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
-
Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000; 191: 771-80.
-
(2000)
J Exp Med
, vol.191
, pp. 771-780
-
-
Kennedy, M.K.1
Glaccum, M.2
Brown, S.N.3
-
14
-
-
0031051547
-
Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor βchain
-
Suzuki H, Duncan GS, Takimoto H, et al. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor βchain. J Exp Med 1997; 185: 499-505.
-
(1997)
J Exp Med
, vol.185
, pp. 499-505
-
-
Suzuki, H.1
Duncan, G.S.2
Takimoto, H.3
-
15
-
-
0032211699
-
IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
-
Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998; 9: 669-76.
-
(1998)
Immunity
, vol.9
, pp. 669-676
-
-
Lodolce, J.P.1
Boone, D.L.2
Chai, S.3
-
16
-
-
0037111585
-
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells
-
Cooper MA, Bush JE, Fehniger TA, et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 2002; 100: 3633-8.
-
(2002)
Blood
, vol.100
, pp. 3633-3638
-
-
Cooper, M.A.1
Bush, J.E.2
Fehniger, T.A.3
-
17
-
-
0038792094
-
IL-15 is an essential mediator of peripheral NK-cell homeostasis
-
Ranson T, Vosshenrich CA, Corcuff E, et al. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 2003; 101: 4887-93.
-
(2003)
Blood
, vol.101
, pp. 4887-4893
-
-
Ranson, T.1
Vosshenrich, C.A.2
Corcuff, E.3
-
18
-
-
38049139119
-
The impact of genetic background and Bid on the phenotype of Bcl-2- deficiency in mice
-
Ni HM, Chen X, Chen L, et al. The impact of genetic background and Bid on the phenotype of Bcl-2- deficiency in mice. Apoptosis 2008; 13: 53-62.
-
(2008)
Apoptosis
, vol.13
, pp. 53-62
-
-
Ni, H.M.1
Chen, X.2
Chen, L.3
-
19
-
-
0033607006
-
Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
-
Yin XM, Wang K, Gross A, et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999; 400: 886-91.
-
(1999)
Nature
, vol.400
, pp. 886-891
-
-
Yin, X.M.1
Wang, K.2
Gross, A.3
-
20
-
-
33750588974
-
The proinflammatory cytokine interleukin-18 alters multiple signaling pathways to inhibit natural killer cell death
-
Hodge DL, Subleski JJ, Reynolds DA, et al. The proinflammatory cytokine interleukin-18 alters multiple signaling pathways to inhibit natural killer cell death. J Interferon Cytokine Res 2006; 26: 706-18.
-
(2006)
J Interferon Cytokine Res
, vol.26
, pp. 706-718
-
-
Hodge, D.L.1
Subleski, J.J.2
Reynolds, D.A.3
-
21
-
-
35148886143
-
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics
-
Yang Y, Kitagaki J, Dai RM, et al. Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res 2007; 67: 9472-81.
-
(2007)
Cancer Res
, vol.67
, pp. 9472-9481
-
-
Yang, Y.1
Kitagaki, J.2
Dai, R.M.3
-
22
-
-
33646033137
-
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen
-
Moffat J, Grueneberg DA, Yang X, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006; 124: 1283-98.
-
(2006)
Cell
, vol.124
, pp. 1283-1298
-
-
Moffat, J.1
Grueneberg, D.A.2
Yang, X.3
-
23
-
-
0031037361
-
The lymphoproliferative disease of granular lymphocytes:updated criteria for diagnosis
-
Semenzato G, Zambello R, Starkebaum G, et al. The lymphoproliferative disease of granular lymphocytes:updated criteria for diagnosis. Blood 1997; 89: 256-60.
-
(1997)
Blood
, vol.89
, pp. 256-260
-
-
Semenzato, G.1
Zambello, R.2
Starkebaum, G.3
-
24
-
-
0035876931
-
Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils
-
Epling-Burnette PK, Zhong B, Bai F, et al. Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol 2001; 166: 7486-95.
-
(2001)
J Immunol
, vol.166
, pp. 7486-7495
-
-
Epling-Burnette, P.K.1
Zhong, B.2
Bai, F.3
-
25
-
-
0027537118
-
Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2
-
Deng G, Podack ER. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci U S A 1993; 90: 2189-93.
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, pp. 2189-2193
-
-
Deng, G.1
Podack, E.R.2
-
26
-
-
0036849781
-
Bax deficiency partially corrects interleukin-7 receptor a deficiency
-
Khaled AR, Li WQ, Huang J, et al. Bax deficiency partially corrects interleukin-7 receptor a deficiency. Immunity 2002; 17: 561-73.
-
(2002)
Immunity
, vol.17
, pp. 561-573
-
-
Khaled, A.R.1
Li, W.Q.2
Huang, J.3
-
27
-
-
0036826914
-
IL-15Ra recycles and presents IL-15 in trans to neighboring cells
-
Dubois S, Mariner J, Waldmann TA, et al. IL-15Ra recycles and presents IL-15 in trans to neighboring cells. Immunity 2002; 17: 537-47.
-
(2002)
Immunity
, vol.17
, pp. 537-547
-
-
Dubois, S.1
Mariner, J.2
Waldmann, T.A.3
-
28
-
-
0034647563
-
Ubiquitinmediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction
-
Breitschopf K, Zeiher AM, Dimmeler S. Ubiquitinmediated degradation of the proapoptotic active form of bid. A functional consequence on apoptosis induction. J Biol Chem 2000; 275: 21648-52.
-
(2000)
J Biol Chem
, vol.275
, pp. 21648-21652
-
-
Breitschopf, K.1
Zeiher, A.M.2
Dimmeler, S.3
-
29
-
-
2542497114
-
The interleukin (IL) -2 family cytokines:survival and proliferation signaling pathways in T lymphocytes
-
Benczik M, Gaffen SL. The interleukin (IL) -2 family cytokines:survival and proliferation signaling pathways in T lymphocytes. Immunol Invest 2004; 33: 109-42.
-
(2004)
Immunol Invest
, vol.33
, pp. 109-142
-
-
Benczik, M.1
Gaffen, S.L.2
-
30
-
-
23944498161
-
Proapoptotic BID is an ATM effector in the DNA-damage response
-
Kamer I, Sarig R, Zaltsman Y, et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 2005; 122: 593-603.
-
(2005)
Cell
, vol.122
, pp. 593-603
-
-
Kamer, I.1
Sarig, R.2
Zaltsman, Y.3
-
31
-
-
23944445368
-
A role for proapoptotic BID in the DNA-damage response
-
Zinkel SS, Hurov KE, Ong C, et al. A role for proapoptotic BID in the DNA-damage response. Cell 2005; 122: 579-91.
-
(2005)
Cell
, vol.122
, pp. 579-591
-
-
Zinkel, S.S.1
Hurov, K.E.2
Ong, C.3
-
32
-
-
10744221485
-
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
-
Vassilev LT, Vu BT, Graves B, et al. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 2004; 303: 844-8.
-
(2004)
Science
, vol.303
, pp. 844-848
-
-
Vassilev, L.T.1
Vu, B.T.2
Graves, B.3
-
33
-
-
85006263913
-
BID regulation by p53 contributes to chemosensitivity
-
Sax JK, Fei P, Murphy ME, et al. BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 2002; 4: 842-9.
-
(2002)
Nat Cell Biol
, vol.4
, pp. 842-849
-
-
Sax, J.K.1
Fei, P.2
Murphy, M.E.3
-
34
-
-
38049059937
-
Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment
-
Tait SW, de Vries E, Maas C, Keller AM, D'Santos CS, Borst J. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. J Cell Biol 2007; 179: 1453-66.
-
(2007)
J Cell Biol
, vol.179
, pp. 1453-1466
-
-
Tait, S.W.1
de Vries, E.2
Maas, C.3
Keller, A.M.4
D'Santos, C.S.5
Borst, J.6
-
35
-
-
34547127636
-
Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1
-
Huntington ND, Puthalakath H, Gunn P, et al. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1. Nat Immunol 2007; 8: 856-63.
-
(2007)
Nat Immunol
, vol.8
, pp. 856-863
-
-
Huntington, N.D.1
Puthalakath, H.2
Gunn, P.3
-
36
-
-
2342553892
-
Mitochondrial p53 activates Bakand causes disruption of a Bak-Mcl1 complex
-
Leu JI, Dumont P, Hafey M, et al. Mitochondrial p53 activates Bakand causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004; 6: 443-50.
-
(2004)
Nat Cell Biol
, vol.6
, pp. 443-450
-
-
Leu, J.I.1
Dumont, P.2
Hafey, M.3
-
37
-
-
0032555697
-
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
-
Li H, Zhu H, Xu CJ, et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
-
(1998)
Cell
, vol.94
, pp. 491-501
-
-
Li, H.1
Zhu, H.2
Xu, C.J.3
-
38
-
-
0035736487
-
HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation
-
Zhou BP, Liao Y, Xia W, et al. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001; 3: 973-82.
-
(2001)
Nat Cell Biol
, vol.3
, pp. 973-982
-
-
Zhou, B.P.1
Liao, Y.2
Xia, W.3
-
39
-
-
0037439151
-
Proapoptotic BID is required for myeloid homeostasis and tumor suppression
-
Zinkel SS, Ong CC, Ferguson DO, et al. Proapoptotic BID is required for myeloid homeostasis and tumor suppression. Genes Dev 2003; 17: 229-39.
-
(2003)
Genes Dev
, vol.17
, pp. 229-239
-
-
Zinkel, S.S.1
Ong, C.C.2
Ferguson, D.O.3
-
40
-
-
34147141585
-
The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest
-
Kaufmann T, Tai L, Ekert PG, et al. The BH3-only protein bid is dispensable for DNA damage- and replicative stress-induced apoptosis or cell-cycle arrest. Cell 2007; 129: 423-33.
-
(2007)
Cell
, vol.129
, pp. 423-433
-
-
Kaufmann, T.1
Tai, L.2
Ekert, P.G.3
-
41
-
-
77954083074
-
In vitro activity of bortezomib in cultures of patient tumour cellspotential utility in haematological malignancies
-
Epub Nov. 18
-
Wiberg K, Carlson K, Aleskog A, et al. In vitro activity of bortezomib in cultures of patient tumour cellspotential utility in haematological malignancies. Med Oncol. Epub 2008 Nov. 18.
-
(2008)
Med Oncol
-
-
Wiberg, K.1
Carlson, K.2
Aleskog, A.3
-
42
-
-
0029097316
-
Molecular controls of growth arrest and apoptosis:p53-dependent and independent pathways
-
Liebermann DA, Hoffman B, Steinman RA. Molecular controls of growth arrest and apoptosis:p53-dependent and independent pathways. Oncogene 1995; 11: 199-210.
-
(1995)
Oncogene
, vol.11
, pp. 199-210
-
-
Liebermann, D.A.1
Hoffman, B.2
Steinman, R.A.3
-
43
-
-
41949136647
-
Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL
-
Liu FT, Agrawal SG, Gribben JG, et al. Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. Blood 2008; 111: 2797-805.
-
(2008)
Blood
, vol.111
, pp. 2797-2805
-
-
Liu, F.T.1
Agrawal, S.G.2
Gribben, J.G.3
-
44
-
-
15944387964
-
The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bikand Bim
-
Nikrad M, Johnson T, Puthalalath H, et al. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bikand Bim. Mol Cancer Ther 2005; 4: 443-9.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 443-449
-
-
Nikrad, M.1
Johnson, T.2
Puthalalath, H.3
-
45
-
-
22244454745
-
Differential regulation of Noxa in normal melanocytes and melanoma cells by proteasome inhibition: Therapeutic implications
-
Fernandez Y, Verhaegen M, Miller TP, et al. Differential regulation of Noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res 2005; 65: 6294-304.
-
(2005)
Cancer Res
, vol.65
, pp. 6294-6304
-
-
Fernandez, Y.1
Verhaegen, M.2
Miller, T.P.3
-
46
-
-
33847328289
-
The Bcl-2 apoptotic switch in cancer development and therapy
-
Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007; 26: 1324-37.
-
(2007)
Oncogene
, vol.26
, pp. 1324-1337
-
-
Adams, J.M.1
Cory, S.2
-
47
-
-
6944241352
-
-
Wei MC. Bcl-2-related genes in lymphoid neoplasia. Int J Hematol 2004; 80: 205-9.
-
Wei MC. Bcl-2-related genes in lymphoid neoplasia. Int J Hematol 2004; 80: 205-9.
-
-
-
|